DAFNA CAPITAL MANAGEMENT LLC Adaptimmune Therapeutics plc Transaction History

DAFNA CAPITAL MANAGEMENT LLC portfolio value:

$377,000
portfolio value

DAFNA CAPITAL MANAGEMENT LLC quarter portfolio value change:

-36.76%
quarter

Adaptimmune Therapeutics plc 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares -220K $1.08 351.06K
Q2 2022 share 0.00% 0 shares -126K $1.7 351.06K
Q1 2022 share Increase +157.63% 214.79K shares 212K $2.06 351.06K
Q4 2021 share Increase 0.00% 136.26K shares 511K $3.87 136.26K
Q3 2016 share Decrease -100.00% -24.95K shares -203K $7.05 0
Q2 2016 share Decrease -71.67% -63.14K shares -513K $8.15 24.95K
Q1 2016 share Increase +83.16% 40K shares 136K $8.13 88.1K